Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Liver Metastases From Solid Tumors: A Prospective Cohort Study

NCT07875465 is registered in ClinicalTrials.gov with Bing Xia as lead sponsor.

NCT NCT07875465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07875465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Liver Metastases From Solid Tumors: A Prospective Cohort Study
Lead sponsor
Bing Xia
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
April 30, 2031
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer (diagnosis), liver metastases, non-small cell lung cancer, pancreatic cancer metastatic, solid tumors